high affinity antibody: Creative Biolabs has established a universal antibody humanization platform to develop high affinity human monoclonal antibodies derived from non-human primates (NHPs). This platform, known as Hi-Affi™ human antibody platform, can offer higher affinity antibodies than humanized antibodies originated from other species, such as widely used murine antibodies.